Jan
19
SYSTEMIC SCLERODERM
Evaluating the safety and efficacy of a novel treatment strategy in systemic sclerosis
Recruiting | Phase III | Systemic Sclerosis | 18–70 years
Overview
This study evaluates the safety and efficacy of a novel treatment strategy in adult patients with systemic sclerosis.
Study population (general)
Adult patients diagnosed with systemic sclerosis.
Principal Investigator
Assoc. Prof., MD Nguyễn Văn Đĩnh
Contact
CTU – Email – Phone